P215 Phase II study with S-1 + low dose docetaxel (N-1 study) for operable breast cancer patients

10.1016/s0960-9776(15)70249-3 ◽

2015 ◽

Vol 24 ◽

pp. S99-S100

Author(s):

Y. Tadokoro ◽

M. Morimoto ◽

M. Nakagawa ◽

H. Takechi ◽

A. Tangoku

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Operable Breast Cancer ◽

Breast Cancer Patients

Download Full-text

Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study)

Clinical Breast Cancer ◽

10.1016/j.clbc.2018.09.008 ◽

2019 ◽

Vol 19 (1) ◽

pp. 10-16 ◽

Author(s):

Misako Nakagawa ◽

Mayumi Ikeuchi ◽

Masami Morimoto ◽

Hirokazu Takechi ◽

Hiroaki Toba ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Operable Breast Cancer ◽

Breast Cancer Patients

Download Full-text

Mitoxantrone, 5-Fluorouracil and Low-dose Leucovorin in Doxorubicin-resistant Advanced Breast Cancer Patients: A Phase II Study

Tumori Journal ◽

10.1177/030089169908500610 ◽

1999 ◽

Vol 85 (6) ◽

pp. 478-482 ◽

Author(s):

Snežana Šušnjar ◽

Suzana Vasović ◽

Zora Nešković-Konstantinović ◽

Ljiljana Stamatović ◽

Vesna Lukić ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Advanced Breast ◽

Breast Cancer Patients

Download Full-text

Phase II Study of HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada471552 ◽

2007 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Phase II Study of a HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada533841 ◽

2010 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study

Acta Oncologica ◽

10.3109/02841860903268031 ◽

2009 ◽

Vol 49 (1) ◽

pp. 35-41 ◽

Author(s):

Annika Malmström ◽

Jörgen Hansen ◽

Lena Malmberg ◽

Lena Carlsson ◽

Jan-Henry Svensson ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Cancer Patients ◽

Treated Breast ◽

Treated Breast Cancer

Download Full-text

Metronomic oral Vinorelbine and Temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A Phase II study

European Journal of Cancer Supplements ◽

10.1016/j.ejcsup.2008.06.032 ◽

2008 ◽

Vol 6 (14) ◽

pp. 116

Author(s):

Liliana Montella ◽

Raffaele Addeo ◽

Gino Leo ◽

Carmine De Rosa ◽

Gregorio Cennamo ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastasis ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Whole Brain Radiotherapy ◽

Breast Cancer Patients ◽

Oral Vinorelbine ◽

Whole Brain ◽

Brain Radiotherapy

Download Full-text

Cisplatin and 5-fluorouracil in refractory breast cancer patients: A phase II study

Breast Cancer Research and Treatment ◽

10.1007/bf01807286 ◽

1988 ◽

Vol 11 (3) ◽

pp. 269-271 ◽

Author(s):

Domenico Amoroso ◽

Paolo Pronzato ◽

Gianfilippo Bertelli ◽

Pietro Gallotti ◽

Gisella Pastorino ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Cancer Patients

Download Full-text

1876 A phase II study of metronomic oral chemotherapy for metastatic breast cancer patients: Safety and efficacy results of vinorelbine, cyclophosphamide plus capecitabine (VEX) combination

European Journal of Cancer ◽

10.1016/s0959-8049(16)30826-7 ◽

2015 ◽

Vol 51 ◽

pp. S291-S292 ◽

Author(s):

E. Montagna ◽

A. Lai ◽

A. Palazzo ◽

V. Bagnardi ◽

G. Cancello ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Oral Chemotherapy ◽

Breast Cancer Patients ◽

Safety And Efficacy

Download Full-text

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)

Annals of Oncology ◽

10.1093/annonc/mdi056 ◽

2005 ◽

Vol 16 (2) ◽

pp. 253-258 ◽

Author(s):

L. Del Mastro ◽

F. Perrone ◽

L. Repetto ◽

L. Manzione ◽

V. Zagonel ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Line Chemotherapy

Download Full-text

5062 Fulvestrant in heavily pre-treated ER-positive post-menopausal metastatic breast cancer patients: final update of a phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70954-1 ◽

2009 ◽

Vol 7 (2) ◽

pp. 279

Author(s):

R. Ratti ◽

Z. Coccorullo ◽

D. Guarneri ◽

G. Addamo ◽

G. Colloca ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Er Positive ◽

Post Menopausal

Download Full-text